6 results

• Nuedexta Chemical Restraint Problems Lead To Investigation By L.A. City Attorney

  October 26, 2017

  Irvin Jackson

  The L.A. City Attorney is now investigating whether the drug Nuedexta was illegally marketed to nursing homes as a form of chemical restraint for dementia patients.

• Nursing Home Nuedexta Prescriptions May Be Newest “Chemical Restraint” for Dementia Patients: CNN

  October 17, 2017

  Irvin Jackson

  Some nursing homes have turned to Nuedexta as a potential chemical restraint for nursing home patients with dementia who act out, which many consider to be a form of nursing home abuse.

• Lawsuit Over Abilify Generic Competition Filed by Otsuka Pharmaceuticals

  September 14, 2016

  Irvin Jackson

  A patent lawsuit has been filed by the makers of Abilify, who say another company is violating its patent by planning to release multiple generic versions of the drug.

• Pfizer Settles Class Action Lawsuit Over Gambling, Sex Addiction Side Effects

  May 11, 2015

  Irvin Jackson

  Pfizer has reached a tentative settlement over claims that Parkinson's disease drugs similar to the antipsychotic Abilify can cause impulsive behavior, like gambling and sex addiction.

• Samsca Liver Injury Warning Issued By FDA

  May 2, 2013

  Irvin Jackson

  Federal drug experts are placing a one month limit on the recommended use of Samsca, a hyponatremia drug that has...

• Samsca Side Effects Linked to Potential Liver Injury Risk: FDA

  January 28, 2013

  Irvin Jackson

  Federal health regulators are warning that the hyponatremia drug Samsca may cause severe and potentially fatal liver damage.